← Eichor
Condition: Recurrent Prostate Adenocarcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Prostate Adenocarcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
Phase N/A · 2 location(s) · Massachusetts General Hospital · NCT06862856SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma
Phase 3 · 6 location(s) · Mayo Clinic · NCT06205316PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE
Phase N/A · 1 location(s) · Azienda Ospedaliero-Universitaria Careggi · NCT05022914An Investigational Scan (rhPSMA-7.3 PET/CT) for Detecting Biochemically Recurrent Prostate Cancer, ENLIGHTEN Trial
EARLY_Phase 1 · 1 location(s) · Northwestern University · NCT06813898Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiot
NA · 1 location(s) · NYU Langone Health · NCT07142967Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas
NA · 2 location(s) · University Health Network, Toronto · NCT05328505Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Essen Biotech · NCT07410494Jump: MR Simulation For Radiation Therapy Master Protocol
NA · 2 location(s) · Brigham and Women's Hospital · NCT04545957Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.
NA · 2 location(s) · Centre Hospitalier Universitaire de la Guadeloupe · NCT06046131Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Phase 3 · 342 location(s) · ECOG-ACRIN Cancer Research Group · NCT04423211Study of Recurrence-directed Therapy (RDT) With or Without Androgen-Deprivation Therapy (ADT) In Patients With Radio-rec
Phase 2 · 3 location(s) · Ontario Clinical Oncology Group (OCOG) · NCT06654336Modifying Metabolic Syndrome and Cardiovascular Risk for Prostate Cancer Patients on ADT Using a Risk Factor Modificatio
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT05054296Alpha-Emitting Radionuclide or Beta-Emitting Radionuclide With Metastasis-Directed Stereotactic Body Radiotherapy for th
Phase 2 · 1 location(s) · Jonsson Comprehensive Cancer Center · NCT07150715Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Pro
Phase 2 · 1 location(s) · Shehzad Basaria, M.D. · NCT06957691
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.